Financhill
Back

Xencor, Inc. Vs. Monopar Therapeutics, Inc. Industry Stock Comparison

Sell
48

XNCR
Xencor, Inc.

Last Price:
$15.29
Seasonality Move:
-1.82%
Sell
41

MNPR
Monopar Therapeutics, Inc.

Last Price:
$71.98
Seasonality Move:
25.93%
Sell
48
Xencor, Inc. (XNCR) is a Sell

Is Xencor, Inc. a Buy, Sell or Hold?

  • The current Xencor, Inc. [XNCR] share price is $15.97. The Score for XNCR is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • XNCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Monopar Therapeutics, Inc. (MNPR) is a Sell

Is Monopar Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Monopar Therapeutics, Inc. [MNPR] share price is $70.92. The Score for MNPR is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MNPR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XNCR Stock Price Chart

What is Xencor, Inc.'s stock price today?

  • The Xencor, Inc. share price today is $15.97
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and XNCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

MNPR Stock Price Chart

What is Monopar Therapeutics, Inc.'s stock price today?

  • The Monopar Therapeutics, Inc. share price today is $70.92
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing slight buying pressure.

XNCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.51 Buy
Relative Strength Index (14 RSI): 49.19 Sell
Chaikin Money Flow: 315029 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.84 - 17.32) Sell
Bollinger Bands (100): (8.79 - 15.73) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.54 Sell
Relative Strength Index (14 RSI): 41.3 Sell
Chaikin Money Flow: 7856 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (71.72 - 85.64) Sell
Bollinger Bands (100): (46.03 - 89.35) Buy

XNCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.24 Sell
20-day SMA: 16.78 Sell
50-day SMA: 15.34 Buy
200-day SMA: 10.88 Buy
8-day EMA: 10 Buy
20-day EMA: 5.2 Buy
50-day EMA: 2.33 Buy
200-day EMA: 0.62 Buy

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.44 Sell
20-day SMA: 77.62 Sell
50-day SMA: 81.13 Sell
200-day SMA: 52.54 Buy
8-day EMA: 71.33 Sell
20-day EMA: 75.43 Sell
50-day EMA: 76.56 Sell
200-day EMA: 56.82 Buy

Xencor, Inc. Earnings Growth & XNCR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.84 per share, and a decrease next year of $0.84 per share.

Monopar Therapeutics, Inc. Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.58 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and a decrease next year of $1.78 per share.

Xencor, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):